These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 8934535)
1. Mechanism of all-trans-retinoic acid-mediated L-myc gene regulation in small cell lung cancer. Ou X; Campau S; Slusher R; Jasti RK; Mabry M; Kalemkerian GP Oncogene; 1996 Nov; 13(9):1893-9. PubMed ID: 8934535 [TBL] [Abstract][Full Text] [Related]
2. All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer. Kalemkerian GP; Jasti RK; Celano P; Nelkin BD; Mabry M Cell Growth Differ; 1994 Jan; 5(1):55-60. PubMed ID: 8123593 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer. Dosaka-Akita H; Akie K; Hiroumi H; Kinoshita I; Kawakami Y; Murakami A Cancer Res; 1995 Apr; 55(7):1559-64. PubMed ID: 7882365 [TBL] [Abstract][Full Text] [Related]
4. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer. Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917 [TBL] [Abstract][Full Text] [Related]
5. Differentiation of human variant small cell lung cancer cell lines to a classic morphology by retinoic acid. Doyle LA; Giangiulo D; Hussain A; Park HJ; Yen RW; Borges M Cancer Res; 1989 Dec; 49(23):6745-51. PubMed ID: 2555051 [TBL] [Abstract][Full Text] [Related]
6. Human lung cancer cell lines exhibit resistance to retinoic acid treatment. Geradts J; Chen JY; Russell EK; Yankaskas JR; Nieves L; Minna JD Cell Growth Differ; 1993 Oct; 4(10):799-809. PubMed ID: 8274449 [TBL] [Abstract][Full Text] [Related]
7. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis. Petty WJ; Li N; Biddle A; Bounds R; Nitkin C; Ma Y; Dragnev KH; Freemantle SJ; Dmitrovsky E J Natl Cancer Inst; 2005 Nov; 97(22):1645-51. PubMed ID: 16288117 [TBL] [Abstract][Full Text] [Related]
8. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins. Risse-Hackl G; Adamkiewicz J; Wimmel A; Schuermann M Oncogene; 1998 Jun; 16(23):3057-68. PubMed ID: 9662339 [TBL] [Abstract][Full Text] [Related]
9. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines. Liu L; Gudas LJ J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002 [TBL] [Abstract][Full Text] [Related]
10. c-myc gene inactivation during induction of nasopharyngeal carcinoma cells with retinoic acid. Jiang N; Zhan F; Cao L; Yao K; Li G Chin Med J (Engl); 2000 Sep; 113(9):823-6. PubMed ID: 11776079 [TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells. Zhuang Y; Faria TN; Chambon P; Gudas LJ Mol Cancer Res; 2003 Jun; 1(8):619-30. PubMed ID: 12805409 [TBL] [Abstract][Full Text] [Related]
12. Retinoic acid causes cell growth arrest and an increase in p27 in F9 wild type but not in F9 retinoic acid receptor beta2 knockout cells. Li R; Faria TN; Boehm M; Nabel EG; Gudas LJ Exp Cell Res; 2004 Mar; 294(1):290-300. PubMed ID: 14980522 [TBL] [Abstract][Full Text] [Related]
13. Effects of tamoxifen and retinoic acid on cell growth and c-myc gene expression in human breast and cervical cancer cells. Tsai LC; Hung MW; Yuan CC; Chao PL; Jiang SY; Chang GG; Chang TC Anticancer Res; 1997; 17(6D):4557-62. PubMed ID: 9494568 [TBL] [Abstract][Full Text] [Related]
14. Expression of the L-myc gene is under positive control by short-lived proteins. Saksela K Oncogene; 1987; 1(3):291-6. PubMed ID: 2838780 [TBL] [Abstract][Full Text] [Related]
15. Retinoic acid-mediated growth inhibition of small cell lung cancer cells is associated with reduced myc and increased p27Kip1 expression. Weber E; Ravi RK; Knudsen ES; Williams JR; Dillehay LE; Nelkin BD; Kalemkerian GP; Feramisco JR; Mabry M Int J Cancer; 1999 Mar; 80(6):935-43. PubMed ID: 10074929 [TBL] [Abstract][Full Text] [Related]
16. Retinoid modulation of c-myc and max gene expression in human breast carcinoma. Sheikh MS; Shao ZM; Chen JC; Ordonez JV; Fontana JA Anticancer Res; 1993; 13(5A):1387-92. PubMed ID: 8239509 [TBL] [Abstract][Full Text] [Related]
17. c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression. Barr LF; Campbell SE; Diette GB; Gabrielson EW; Kim S; Shim H; Dang CV Cancer Res; 2000 Jan; 60(1):143-9. PubMed ID: 10646866 [TBL] [Abstract][Full Text] [Related]
18. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells. St-Arnaud R; Nepveu A; Marcu KB; McBurney MW Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960 [TBL] [Abstract][Full Text] [Related]
19. A combination treatment of c-myc antisense DNA with all-trans-retinoic acid inhibits cell proliferation by downregulating c-myc expression in small cell lung cancer. Akie K; Dosaka-Akita H; Murakami A; Kawakami Y Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):243-9. PubMed ID: 10984118 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4. Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]